Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled dose-ranging study of JNJ-95597528 in adults with inadequately controlled moderate-to-severe asthma
MOH_2026-08-23_017001Phase 2Not yet recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JNJ-95597528 in asthma (4 arms), sponsored by Janssen Pharmaceutical. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
JNJ-95597528
03
Conditions
asthma
Beyond the preview
Go deeper on MOH_2026-08-23_017001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-08-23_017001.